entertainment -WSS

entertainment

author：focus 2025-09-30 00:48:32 - browse：37

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： After Sarepta trial failure, Duchenne families brace for more debate

WSS

Prime Medicine says its gene editing passes test in monkeys

Use doctors trained outside the U.S. to ease the physician shortage

Canadians with cystic fibrosis outlive Americans by a decade

Drug cartel violence flares in western Mexico after vigilante leader's killing

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Wikipedia

entertainment

knowledge

Drug repurposing or repositioning? The language matters

Infant mortality in U.S. rose last year for first time in decades: CDC

What does generative AI mean for health care? We asked experts

Fatty liver disease was alleviated by Lilly’s ‘triple

23andMe had bad news about my health. I wish a person had delivered it

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

United colonoscopy coverage change 'may cost lives,' doctors say

DeepMind touts AlphaFold's new skills as protein folding AI models face off

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

hotspot

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Medicare proceeds with plan to claw back hospital funds

Gene therapy’s promise and the high cost of hope

Inari Medical to buy amputation prevention company LimFlow

How to convince healthy people to buy insurance

hotspot

hotspot

knowledge

leisure time